Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02207322 · ClinicalTrials.gov registry record · NA
Supportive Care Intervention In Patients Hospitalized For Hematopoietic Stem Cell Transplantation (Shield)
A NA study of Complication of Transplant, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT02207322 is a NA study of Complication of Transplant that has completed, run by Massachusetts General Hospital. The registered enrollment target is 160 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02207322, a NA study of Complication of Transplant, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
The main purpose of this study is to assess whether early integration of palliative and supportive care services in care of patients hospitalized for hematopoietic stem cell transplantation (HSCT) can improve patients' and family caregivers' quality of life and mood.
Conditions Studied
Interventions
- OTHER transplant with early palliative care
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2014-08 |
| Est. Completion | 2017-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02207322
The ClinicalTrials.gov registry entry for NCT02207322 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Complication of Transplant appearing as the primary indexed condition, and to 1 intervention - of which transplant with early palliative care is the first listed.
NCT02207322 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02207322 about?
NCT02207322 is a clinical study titled "Supportive Care Intervention In Patients Hospitalized For Hematopoietic Stem Cell Transplantation (Shield)". The main purpose of this study is to assess whether early integration of palliative and supportive care services in care of patients hospitalized for hematopoietic stem cell transplantation (HSCT) can improve patients' and family caregivers' quality of life and mood.
What is the current status of trial NCT02207322?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2014-08. Estimated completion is 2017-08.
What conditions does trial NCT02207322 study?
This clinical trial studies the following conditions: Complication of Transplant.
What interventions are being tested in trial NCT02207322?
The interventions under investigation include: transplant with early palliative care (OTHER).
Who is sponsoring clinical trial NCT02207322?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02207322 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.